Kidney Disease in Type 2 Diabetes: Optimizing Renal Protection


On completion of this program, participants should be able to:

  • Describe CKD and the available treatment options to optimize renal protection
  • Review the efficacy and safety of SGLT2 inhibitors in patients with T2D and CKD
  • Highlight the role of the community pharmacist in managing patients with CKD